Global Occlusion Devices Market Size, Share, Opportunities, And Trends By Type (Occlusion Removal Devices, Embolization Devices, Tubal Occlusion Devices), By Application (Cardiology, Gynaecology, Neurology, Urology, Others), By End Users (Hospitals, Ambulatory Surgical Centers) And By Geography - Forecasts From 2025 To 2030

Report CodeKSI061611891
PublishedOct, 2025

Description

Occlusion Devices Market Size:

The global occlusion devices market is projected to rise at a 5.51% CAGR, achieving USD 4.423 billion in 2030 from USD 3.383 billion in 2025.

Occlusion refers to the blockage or closure in the blood vessel or any other organ of the body. Occlusion devices are used to remove such blockages to retain blood flow in the vessel or the organising minimally invasive surgeries. The devices are used to cure to cure cardiovascular defects, gynaecological defects, neurological defects etc. The market is expected to show a robust growth during the given forecast period. The growth in the market may be attributed to the rising patient population base owing to the increase in the prevalence of cardiovascular, neurological and other disorders needing occlusion removal. Rising adoption of the minimally invasive surgeries across the globe coupled with the favourable reimbursement policies will also boost the market for the occlusion devices through to2023. However, stringent regulatory requirements for the market approval of such devices along with the lack of trained and skilled professionals might restrain the growth of the market the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global occlusion devices market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global occlusion devices market.

Major industry players profiled as part of the report are Terumo Europe NV, Abbott and Medtronic among others.

Segmentation

  • GLOBAL OCCLUSION DEVICES MARKET BY TYPE
    • Occlusion Removal Devices
    • Embolization Devices
    • Tubal Occlusion Devices
  • GLOBAL OCCLUSION DEVICES MARKET BY APPLICATION
    • Cardiology
    • Gynaecology
    • Neurology
    • Urology
    • Others
  • GLOBAL OCCLUSION DEVICES MARKET BY END-USERS
    • Hospitals
    • Ambulatory SurgIcal Centers
  • GLOBAL OCCLUSION DEVICES MARKET BY GEOGRAPHY
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Indonesia
      • Thailand
      • Others

Table Of Contents

1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
    2.1. Market Overview
    2.2. Market Definition
    2.3. Scope of the Study
    2.4. Market Segmentation
3. BUSINESS LANDSCAPE
    3.1. Market Drivers
    3.2. Market Restraints
    3.3. Market Opportunities
    3.4. Porter’s Five Forces Analysis
    3.5. Industry Value Chain Analysis
    3.6. Policies and Regulations
    3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL OCCLUSION DEVICES MARKET BY TYPE
    5.1. Introduction
    5.2. Occlusion Removal Devices
    5.3. Embolization Devices
    5.4. Tubal Occlusion Devices
6. GLOBAL OCCLUSION DEVICES MARKET BY APPLICATION
    6.1. Introduction
    6.2. Cardiology
    6.3. Gynaecology
    6.4. Neurology
    6.5. Urology
    6.6. Others
7. GLOBAL OCCLUSION DEVICES MARKET BY END-USERS
    7.1. Introduction
    7.2. Hospitals
    7.3. Ambulatory SurgIcal Centers
8. GLOBAL OCCLUSION DEVICES MARKET BY GEOGRAPHY
    8.1. Introduction
    8.2. North America
        8.2.1. USA
        8.2.2. Canada
        8.2.3. Mexico
    8.3. South America
        8.3.1. Brazil
        8.3.2. Argentina
        8.3.3. Others
    8.4. Europe
        8.4.1. Germany
        8.4.2. France
        8.4.3. United Kingdom
        8.4.4. Spain
        8.4.5. Others
    8.5. Middle East and Africa
        8.5.1. Saudi Arabia
        8.5.2. UAE
        8.5.3. Others
    8.6. Asia Pacific
        8.6.1. China
        8.6.2. India
        8.6.3. Japan
        8.6.4. South Korea
        8.6.5. Indonesia
        8.6.6. Thailand
        8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
    9.1. Major Players and Strategy Analysis
    9.2. Market Share Analysis
    9.3. Mergers, Acquisitions, Agreements, and Collaborations
    9.4. Competitive Dashboard
10. COMPANY PROFILES
    10.1. Abbott
    10.2. Penumbra, Inc.
    10.3. Medtronic
    10.4. AtriCure, Inc.
    10.5. Terumo Europe NV
    10.6. Neuravi
    10.7. Prytime Medical Devices, Inc
    10.8. Acrostak Int.
    10.9. ArtVentive Medical Group, Inc.
    10.10. EndoShape, Inc
11. APPENDIX
    11.1. Currency
    11.2. Assumptions
    11.3. Base and Forecast Years Timeline
    11.4. Key benefits for the stakeholders
    11.5. Research Methodology
    11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES

Companies Profiled

Abbott

Penumbra, Inc

Medtronic

AtriCure, Inc

Terumo Europe NV

Neuravi

Prytime Medical Devices, Inc

Acrostak Int

ArtVentive Medical Group, Inc

EndoShape, Inc

Related Reports